0001562180-24-000541.txt : 20240118
0001562180-24-000541.hdr.sgml : 20240118
20240118172123
ACCESSION NUMBER: 0001562180-24-000541
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240108
FILED AS OF DATE: 20240118
DATE AS OF CHANGE: 20240118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grund Nicholas
CENTRAL INDEX KEY: 0001661887
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 24542816
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
3
1
primarydocument.xml
PRIMARY DOCUMENT
X0206
3
2024-01-08
1
0001517022
Akebia Therapeutics, Inc.
AKBA
0001661887
Grund Nicholas
C/O AKEBIA THERAPEUTICS, INC
245 FIRST ST.
CAMBRIDGE
MA
02142
false
true
false
false
Chief Commercial Officer
/s/Carolyn Rucci, attorney-in-fact for Nicholas Grund
2024-01-18
EX-24
2
poa_ngrundjan24.txt
POA
POWER OF ATTORNEY
Know all by these present, that the undersigned hereby
constitutes and appoints each of John P. Butler, Ellen Snow, Nicole R. Hadas
and Carolyn Rucci signing singly, as the undersigneds true and lawful
attorney-in-fact to:
(1) prepare, execute in the undersigneds name and on the
undersigneds behalf, and submit to the U.S. Securities and Exchange
Commission (the SEC) a Form ID, including amendments thereto, and any
other documents necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings with the SEC of
reports required by Section 16(a) of the Securities Exchange Act of 1934,
as amended (the Act) or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in
the undersigneds capacity as an officer, director and/or
shareholder of Akebia Therapeutics, Inc. (the Company),
Forms 3, 4 and 5 in accordance with Section 16(a) of the Act,
and the rules thereunder, or Forms 144 in accordance with Rule 144
under the Securities Act of 1933, as amended (Rule 144);
(3) do and perform any and all acts for and on behalf
of the undersigned that may be necessary or desirable to complete
and execute any such Form 3, 4 or 5 or Form 144, and timely file such form
with the SEC and any stock exchange or similar authority; and
(4) take any other action of any type whatsoever in
connection with the foregoing that, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest of, or
legally required by, the undersigned, it being understood that the
documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form
and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-facts discretion.
The undersigned hereby grants to each attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any ofthe rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all the acts such attorney-in-fact
shall lawfully do or cause to be done by virtue of this Power of Attorney and
the rights and powers herein granted. The undersigned acknowledges that each
of the foregoing attorneys-in-fact, in serving in such capacity at the request
of the undersigned, is not assuming any of the undersigneds responsibilities to
comply with Section 16 of the Act or Rule 144.
This Power of Attorney supersedes any power of attorney previously
executed by the undersigned regarding the purposes outlined in the first
paragraph hereof. This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4 and 5, or
Forms 144, with respect to the undersigneds holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in
a signed writing delivered to each of the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of January 12, 2024.
By:
/s/ Nicholas Grund
Name:
Nicholas Grund